Zobrazeno 1 - 10
of 166
pro vyhledávání: '"Tamar H Taddei"'
Autor:
Yapei Zhang, Catherine Mezzacappa, Lin Shen, Amanda Ivatorov, Alexandra Petukhova-Greenstein, Rajni Mehta, Maria Ciarleglio, Yanhong Deng, Woody Levin, Steve Steinhardt, Donna Connery, Michael Pineau, Ifeyinwa Onyiuke, Caroline Taylor, Michal G Rose, Tamar H Taddei
Publikováno v:
PLOS Digital Health, Vol 1, Iss 8, p e0000080 (2022)
IntroductionHepatocellular carcinoma (HCC) requires complex care coordination. Patient safety may be compromised with untimely follow-up of abnormal liver imaging. This study evaluated whether an electronic case-finding and tracking system improved t
Externí odkaz:
https://doaj.org/article/9f6290ff10b846bda278d6e9f1fa0709
Autor:
Christopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, Lesley S Park, Joseph T King, Melissa Skanderson, Ronald G Hauser, Anna Schultze, Christopher I Jarvis, Mark Holodniy, Vincent Lo Re, Kathleen M Akgün, Kristina Crothers, Tamar H Taddei, Matthew S Freiberg, Amy C Justice
Publikováno v:
PLoS Medicine, Vol 17, Iss 9, p e1003379 (2020)
BackgroundThere is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-1
Externí odkaz:
https://doaj.org/article/7251956a83a8471285adcd51c0945ecc
Autor:
Jennifer Uyei, Tamar H Taddei, David E Kaplan, Michael Chapko, Elizabeth R Stevens, R Scott Braithwaite
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221614 (2019)
BackgroundHepatocelluar cancer (HCC) is the leading cause of death among people with hepatitis C virus (HCV)-related cirrhosis. Our aim was to determine the optimal surveillance frequency for patients with HCV-related compensated cirrhosis.MethodsWe
Externí odkaz:
https://doaj.org/article/e81e176e99744cababae77c9134eb614
Autor:
Jan C. DeNofrio, Manisha Verma, Andrzej S. Kosinski, Victor Navarro, Tamar H. Taddei, Michael L. Volk, Marie Bakitas, Kavitha Ramchandran
Publikováno v:
Hepatology Communications, Vol 6, Iss 4, Pp 920-930 (2022)
Palliative care (PC) benefits patients with serious illness including end‐stage liver disease (ESLD). As part of a cluster randomized trial, hepatologists were trained to deliver primary palliative care to patients with ESLD using an online course,
Externí odkaz:
https://doaj.org/article/82bedad031f447908eba66b17c9d5044
Autor:
Jessica Howell, Amit Samani, Binish Mannan, Saur Hajiev, Leila Motedayen Aval, Rebecca Abdelmalak, Vincent C. Tam, Dominik Bettinger, Robert Thimme, Tamar H. Taddei, David E. Kaplan, Max Seidensticker, Rohini Sharma
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: The impact of nonalcoholic fatty liver disease (NAFLD) on overall survival (OS), treatment response and toxicity in patients with hepatocellular carcinoma (HCC) treated with sorafenib is unknown. We examined the impact of NAFLD on surviva
Externí odkaz:
https://doaj.org/article/2026d240276c41bbb479f1e045540862
Publikováno v:
Journal of Multidisciplinary Healthcare. 16:1531-1540
Yueming Cao,1 Catherine Mezzacappa,1,2 Ariel Jaffe,1,2 Mario Strazzabosco,1,2 Tamar H Taddei1,2 1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; 2Department of Internal Medicine Digestive Disease Section, Yale School of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf165e343de0fadc0d8c069b2f7ceabe
https://doi.org/10.2147/jmdh.s407908
https://doi.org/10.2147/jmdh.s407908
Autor:
Binu V. John, Dustin Bastaich, Gwilym Webb, Teresa Brevini, Andrew Moon, Raphaella D. Ferreira, Allison M. Chin, David E. Kaplan, Tamar H. Taddei, Marina Serper, Nadim Mahmud, Yangyang Deng, Hann‐Hsiang Chao, Fotios Sampaziotis, Bassam Dahman
Publikováno v:
Journal of Internal Medicine. 293:636-647
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b0ac10a1020b43f10867e3d0c822c10
https://doi.org/10.1111/joim.13630
https://doi.org/10.1111/joim.13630
Publikováno v:
Gastroenterology. 164:177-181
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0a8366672ea23d53a1e977510456db
https://doi.org/10.1053/j.gastro.2022.11.006
https://doi.org/10.1053/j.gastro.2022.11.006
Autor:
Binu V. John, Raphaella D. Ferreira, Akash Doshi, David E. Kaplan, Tamar H. Taddei, Seth A. Spector, Elizabeth Paulus, Yangyang Deng, Dustin Bastaich, Bassam Dahman
Publikováno v:
Journal of Hepatology. 77:1349-1358
Cirrhosis is associated with immune dysregulation and hyporesponsiveness to several vaccines including those against COVID-19. Our aim was to compare outcomes between patients with cirrhosis who received 3 doses of either the Pfizer BNT162b2 mRNA or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4a5b3d6c039cd71e337d49e202e5e08
https://doi.org/10.1016/j.jhep.2022.07.036
https://doi.org/10.1016/j.jhep.2022.07.036
Autor:
Marina Serper, David E. Kaplan, Tamar H. Taddei, Elliot B. Tapper, Jordana B. Cohen, Nadim Mahmud
Publikováno v:
Hepatology. 77:489-500
Little is known about the effectiveness of nonselective beta blockers (NSBBs) in preventing hepatic decompensation in routine clinical settings. We investigated whether NSBBs are associated with hepatic decompensation or liver-related mortality in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c15d5b67087ce65efbbd237e2ba35367
https://doi.org/10.1002/hep.32737
https://doi.org/10.1002/hep.32737